Kazuhiko Yamada

Title: Kazuhiko Yamada: Innovator in Tumor Treatment

Introduction

Kazuhiko Yamada is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has led to the development of a unique pharmaceutical composition that is used in combination therapy.

Latest Patents

Kazuhiko Yamada holds 1 patent for a tumor-treating pharmaceutical composition. This composition is designed for use in combination therapy with lenvatinib and a specific compound known as (6S,9aS)—N-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-6-(2-fluoro-4-hydroxybenzyl)-4,7-dioxo-2-(prop-2-en-1-yl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide. This innovative approach aims to enhance the effectiveness of cancer treatments.

Career Highlights

Kazuhiko Yamada is associated with Eisai R&D Management Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from tumors.

Collaborations

He collaborates with notable colleagues, including Yoichi Ozawa and Yusaku Hori. Their combined expertise contributes to the innovative projects at Eisai R&D Management Co., Ltd.

Conclusion

Kazuhiko Yamada's contributions to tumor treatment through his patented pharmaceutical composition highlight his role as a key innovator in the field. His ongoing work promises to make a significant impact on cancer therapy.